Cost Per-Responder Analysis of Secukinumab Compared to Other Biologics for Treatment of Moderate to Severe Psoriasis Patients in Saudi Arabia
Abstract
Authors
M Al Howimel K Al Jufan A AlAlwan N Alshehri A Al Amri H Al Hamdan H Al Mudaiheem N Zakaria L Al Kateb I Gilloteau CN Graham M Sekharan